Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: The early start of a dangerous situation

Archives of Medical Research

Volumn 36, Issue 3, 2005, Pages 241-249

  Caballero, A Enrique ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Diabetes; Endothelial function; Inflammation; Insulin resistance; Obesity; Pre diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CYTOKINE; HORMONE; METFORMIN;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE PREDISPOSITION; FAMILY HISTORY; GLUCOSE TOLERANCE; HUMAN; INFLAMMATION; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PREGNANCY DIABETES MELLITUS; REVIEW; RISK ASSESSMENT; RISK FACTOR; VASCULAR DISEASE;

EID: 19944419117     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2005.03.013     Document Type: Article

References (79)

1. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1998 1414 1431
2. S.M. Haffner, L. Mykkanen, A. Festa, J.P. Burke, and M.P. Stern Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state Circulation 101 2000 975 980
3. F.B. Hu, M.J. Stampfer, S.M. Haffner, C.G. Solomon, W.C. Willet, and J.E. Manson Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes Diabetes Care 25 2002 1129 1134
4. G.L. King, and H. Wakasaki Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes Diabetes Care 22 1999 C31 C37
5. M. Pyorala, H. Miettinen, P. Halonen, M. Laakso, and K. Pyorala Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study Arterioscler Thromb Vasc Biol 20 2000 538 544
6. A.E. Caballero Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes Curr Diabetes Rep 4 2004 237 246
7. J.P. Depres, M. Lamarche, P. Mauriege, B. Cantin, G.R. Dagenais, S. Moorjani, and P.J. Lupien Hyperinsulinemia as an independent risk factor for ischemic heart disease N Engl J Med 334 1996 952 957
8. G. Howard, D.H. O'Leary, D. Zaccaro, S.M. Haffner, M. Rewers, R. Hamman, J.V. Selby, M.F. Saad, P. Savage, and R. Bergman Insulin sensitivity and athersoclerosis Circulation 93 1996 1809 1817
9. H.O. Steinberg, H. Chaker, R. Leaming, A. Johnson, G. Brechtel, and A. Baron Obesity/insulin resistance is associated with endothelial dysfunction J Clin Invest 97 1996 2601 2610
10. A.E. Caballero Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease Obes Res 11 2003 1278 1289
11. B.B. Kahn, and J.S. Flier Obesity and insulin resistance J Clin Invest 106 2000 473 481
12. J.E. Gerich Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus Mayo Clin Proc 78 2003 411 413
13. A.A. Quyyumi Endothelial function in health and disease: new insights into the genesis of cardiovascular disease Am J Med 105 1998 S32 S39
14. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
15. T. Mano, T. Masuyama, K. Yamamoto, J. Naito, H. Kondo, R. Nagano, J. Tanouchi, M. Hori, M. Inoue, and T. Kamada Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessable with intravascular ultrasound Am Heart J 131 1996 231 238
16. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
17. J.P. Halcox, W.H. Schenke, G. Zalos, R. Mincemoyer, A. Prasad, M.A. Waclawiw, K.R. Nour, and A.A. Quyyumi Prognostic value of coronary vascular endothelial dysfunction Circulation 106 2002 653 658
18. N. Gokce, J.F. Keaney, L.M. Hunter, M.T. Watkins, Z.S. Nedeljikovic, J.O. Menzoian, and J.A. Vita Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease J Am Coll Cardiol 41 2003 1769 1775
19. S.C. Lim, A.E. Caballero, P. Smakowski, F.W. LoGerfo, E.S. Horton, and A. Veves Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria Diabetes Care 22 1999 1865 1870
20. S.-J. Hwang, C.M. Ballantyne, R. Sharrett, L.C. Smith, C.E. Davis, A.M. Gotto Jr., and E. Boerwinkle Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study Circulation 96 1997 4219 4225
21. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
22. P.M. Ridker, J.E. Buring, N.R. Cook, and N. Rifai C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women Circulation 107 2003 391 397
23. M.I. Schmidt, B.B. Duncan, A.R. Sharrett, G. Lindberg, P.J. Savage, S. Offenbacher, M.I. Azambuja, R.P. Tracy, and G. Heiss Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study Lancet 353 1999 1649 1652
24. A.D. Pradhan, J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker C-reactive protein, interleukin-6 and risk of developing type 2 diabetes JAMA 286 2001 327 334
25. A. Festa, R. D'Agostino Jr., R.P. Tracy, and S.M. Haffner Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study Diabetes 51 2002 1131 1137
26. J.B. Meigs, F.B. Hu, N. Rifai, and J.E. Manson Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus JAMA 291 2004 1978 1986
27. M.G. Clark, M.G. Wallis, E.J. Barrett, M.A. Vincent, S.M. Richards, L.H. Clerk, and S. Rattigan Blood flow and muscle metabolism: a focus on insulin action Am J Physiol Endocrinol Metab 284 2003 E241 E258
28. E.H. Serne, R.G. Ijzerman, R.O. Gans, R. Nijveldt, G. De Vries, R. Evertz, A.J. Donker, and C.D. Stehouwer Direct evidence for insulin-induced capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia Diabetes 51 2002 1515 1522
29. P.D. Miles, M. Levisetti, D. Reichart, M. Khoursheed, A.R. Moossa, and J.M. Olefsky Kinetics of insulin action in vivo: identification of rate-limiting steps Diabetes 44 1995 947 953
30. R.C. Bonadonna, M.P. Saccomani, S. Del Prato, E. Bonora, R.A. DeFronzo, and C. Cobelli Role of tissue-specific blood flow and tissue recruitment in insulin mediated glucose uptake of human skeletal muscle Circulation 98 1998 234 241
31. D.J. Freeman, J. Norrie, N. Sattar, R.D. Neely, S.M. Cobbe, I. Ford, C. Isles, A.R. Lorimer, P.W. Macfarlane, J.H. McKillop, C.J. Packard, J. Shepherd, and A. Gaw Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study Circulation 103 2001 357 362
32. S. Yusuf, H. Gerstein, B. Hoogwerf, J. Pogue, J. Bosch, B.H. Wolffenbuttel, B. Zinman, and HOPE Study Investigators Ramipril and the development of diabetes JAMA 286 2001 1882 1885
33. A.E. Caballero, S. Arora, R. Saouaf, S.C. Lim, P. Smakowski, J. Park, G.L. King, F.W. LoGerfo, E.S. Horton, and A. Veves Micro and macro-vascular reactivity is reduced in subjects at risk for type 2 diabetes Diabetes 48 1999 1856 1862
34. B.M. Balletshofer, K. Rittig, M.D. Enderle, A. Volk, E. Maerker, S. Jacob, S. Matthaei, K. Rett, and H.U. Haring Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance Circulation 101 2000 1780 1784
35. A. Goldfine, J. Beckman, H. Devlin, S. Hurley, and M. Creager The role of a family history of diabetes on endothelial function J Am Coll Cardiol 43 2004 468A
36. A. Gurlek, M. Bayraktar, and S. Kirazli Increased plasminogen activator-1 in offspring of type 2 diabetic patients Diabetes Care 23 2000 88 92
37. N. Pannacciulli, G. De Pergola, F. Giorgino, and R. Giorgino A family history of type 2 diabetes is associated with increased plasma levels of C-reactive protein in non-smoking healthy adult women Diabet Med 19 2002 689 692
38. K.D. Hopkins, E.D. Lehmann, R.L. Jones, R.C. Turay, and R.G. Gosling A family history of NIDDM is associated with decreased aortic distensibility in normal healthy young adult subjects Diabetes Care 19 1996 501 503
39. N. Pannacciulli, G. De Pergola, M. Ciccone, P. Rizzon, F. Giorgino, and R. Giorgino Effect of family history of type 2 diabetes on the intima-media thickness of the common carotid artery in normal weight, overweight, and obese glucose-tolerant young adults Diabetes Care 26 2003 1230 1234
40. E. Anastasiou, J.P. Leakakis, M. Alevizaki, C.M. Papamichael, J. Megas, A. Souvatzoglou, and S.F. Stamatelopoulos Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes Diabetes Care 21 1998 2111 2115
41. M.M. Hannemann, W.G. Liddell, A.C. Shore, P.M. Clark, and J.E. Tooke Vascular function in women with previous gestational diabetes J Vasc Res 39 2002 311 319
42. R. Bergholm, M. Tiikkainen, S. Venkavaara, M. Tamminen, K. Teramo, A. Rissanen, and H. Yki-Jarvinen Lowering LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilation in obese women with previous gestational diabetes Diabetes Care 26 2003 1667 1672
43. J.P. Lekakis, E.A. Anastasiou, C.M. Papamichael, K.S. Stamatelopoulous, A.G. Dagre, M.C. Alevizaki, and S.F. Stamatelopoulos Short-term oral ascorbic acid improves endothelium-dependent vasodilation in women with a history of gestational diabetes mellitus Diabetes Care 23 2000 1432 1434
44. G. Paradisi, H.O. Steinberg, A. Hempfling, J. Cronin, G. Hook, M.K. Shepard, and A.D. Baron Polycystic ovary syndrome is associated with endothelial dysfunction Circulation 103 2001 1410 1415
45. K.J. Mather, S. Verma, B. Corenblum, and T.J. Anderson Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome J Clin Endocrinol Metab 85 2000 1851 1856
46. C.C. Kelly, H. Lyall, J.R. Petrie, G.W. Gould, J.M. Connell, and N. Sattar Low grade chronic inflammation in women with polycystic ovarian syndrome J Clin Endocrinol Metab 86 2001 2453 2455
47. E.O. Talbott, D.S. Guzick, K. Sutton-Tyrrell, K.P. McHugh-Pemu, J.V. Zborowski, K.E. Remsberg, and L.H. Kuller Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women Arterioscler Thromb Vasc Biol 20 2000 2414 2421
48. DPP Research Group The effect of lifestyle modification and metformin on markers CRP, fibrinogen and tPA in the DPP Diabetes 2003 A79
49. K. Esposito, F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, M. Ciotola, L. Quagliaro, A. Ceriello, and D. Giugliano Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress Circulation 106 2002 2067 2072
50. S. Vehkavaara, A. Seppala-Lindroos, J. Westerbacka, P.H. Groop, and H. Yki-Jarvinen In vivo endothelial dysfunction characterizes patients with impaired fasting glucose Diabetes Care 22 1999 2055 2060
51. A.E. Caballero, A. Delgado, A. Naranjo, J.L. Castillo, T. Cabrera, L. Braun, C.A. Aguilar-Salinas, and F.J. Gomez-Perez Metformin improves markers of endothelial activation but not markers of inflammation in subjects with impaired glucose tolerance J Clin Endocrinol Metab 89 2004 3943 3948
52. S.M. Grundy, B. Hansen, S.C. Smith, J.I. Cleeman, and R.A. Kahn Clinical management of metabolic syndrome. Report of the American Heart Association/National Heart, Lung and Blood Institute/ American Diabetes Association Conference on Scientific Issues Related to Management Circulation 109 2004 551 556
53. J.K. Ninomiya, G. L'Italien, M.H. Criqui, J.L. Whyte, A. Gamst, and R.S. Chen Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrtion Examination Survey Circulation 109 2004 42 46
54. L. Lind Lipids and endothelium dependent vasodilation - a review Lipids 37 1 2002 1 15
55. C. Ferri, G. Desideri, R. Baldoncini, B. Bellini, C. De Angelis, C. Mazzocchi, and A. Santucci Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities Diabetes 47 1998 660 667
56. S.C. Lim, A.E. Caballero, P. Smakowski, F.W. LoGerfo, E.S. Horton, and A. Veves Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria Diabetes Care 22 1999 1865 1870
57. S. Vigili de Kreutzenberg, E. Kiwanuka, A. Tiengo, and A. Avogaro Visceral obesity is characterized by impaired nitric oxide-independent vasodilation Eur Heart J 24 2003 1210 1215
58. P. Tounian, Y. Aggoun, B. Dubern, V. Varille, B. Guy-Grand, D. Sidi, J.P. Girardet, and D. Bonnet Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study Lancet 358 2001 1400 1404
59. M.J. Jarvisalo, A. Harmoinen, M. Hakanen, U. Paakkunainen, J. Viikari, J. Hartiala, T. Lehtimaki, O. Simell, and O.T. Raitakari Elevated serum C-reactive protein levels and early arterial changes in healthy children Arterioscler Thromb Vasc Biol 22 2002 1323 1328
60. A.H. Slyper What vascular ultrasound testing has revealed abut pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment J Clin Endocrinol Metab 89 2004 3089 3095
61. M.E. Griffin, M.J. Marcucci, G.W. Cline, K. Bell, N. Barucci, D. Lee, L.J. Goodyear, E.W. Kraegen, M.F. White, and G.I. Shulman Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade Diabetes 48 1999 1270 1274
62. H.O. Steinberg, and A.D. Baron Vascular function, insulin resistance and fatty acids Diabetologia 45 2002 623 634
63. G. Winkler, P. Lakatos, F. Salamon, Z. Nagy, G. Speer, M. Kovacs, G. Harmos, O. Dworak, and K. Cseh Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients Diabet Med 16 1999 207 211
64. J.S. Yudkin, M. Kumari, S.E. Humphries, and V. Mohamed-Ali Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148 2002 209 214
65. I. Jialal, S. Devaraj, and S.K. Venugopal C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004;May 17 (Epub ahead of print.)
66. Y.B. Kim, S. Uotani, D.D. Perroz, J.S. Flier, and B.B. Kahn In vivo administration of leptin activates signal transduction directly in insulin sensitive tissues: overlapping but distinct pathways from insulin Endocrinology 141 2000 2328 2339
67. G. Lembo, C. Vecchione, L. Fratta, G. Marino, V. Trimarco, G. d'Amati, and B. Trimarco Leptin induces direct vasodilation through distinct endothelial mechanisms Diabetes 49 2000 293 297
68. C.M. Steppan, S.T. Bailey, S. Bhat, E.J. Brown, R.R. Banerjee, C.M. Wright, H.R. Patel, R.S. Ahima, and M.A. Lazar The hormone resistin links obesity to diabetes Nature 409 2001 307 312
69. T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, and T. Kadowaki Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 2003 762 769
70. H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, and M.J. Quon Adiponectin stimulates production of nitric oxide in vascular endothelial cells J Biol Chem 278 2003 45021 45026
71. O. Hamdy, S. Ledbury, C. Mullooly, C. Jarema, S. Porter, K. Ovalle, A. Moussa, A.E. Caballero, P.A. Economides, A. Veves, and E.S. Horton Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome Diabetes Care 26 2003 2110 2125
72. W. Hsueh, and D. Bruemmer Peroxisome proliferator-activated receptor γ: implications for cardiovascular disease Hypertension 43 2004 297 305
73. A.E. Caballero, R. Saouaf, S.C. Lim, O. Hamdy, C. O'Connor, K. Abuelenin, F.W. LoGerfo, E.S. Horton, and A. Veves The effects of troglitazone on the endothelial function of the micro-and macrocirculation in patients with early and late type 2 diabetes Metabolism 52 2003 173 180
74. P. Dandona, A Aljada, and A. Chaudhuri Vascular reactivity and thiazolidinediones Am J Med 115 2003 S81 S86
75. M.A. Charles, P. Morange, E. Eschwege, P. Andre, P. Vague, and I. Juhan-Vague Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects. The BIGPRO1 Study Diabetes Care 21 1998 1967 1972
76. K. Kuboki, Z.Y. Jiang, N. Takahara, S.E. Ha, M. Igarashi, T. Yamauchi, E.P. Feener, T.P. Herbert, C.J. Rhodes, and G.L. King Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells in vivo: a specific vascular action of insulin Circulation 101 2000 676 681
77. K. Cusi, K. Maezono, A. Osman, M. Pendergrass, M.E. Patti, T. Pratipanawatrr, R.A. DeFronzo, C.R. Kahn, and L.J. Mandarino Insulin resistance differentially affects the PI-3-kinase and MAP Kinase mediated signaling in human muscle J Clin Invest 105 2000 311 320
78. W.A. Hsueh, and R.E. Law Insulin signaling in the arterial wall Am J Cardiol 84 1999 21J 24J
79. Z.Y. Jiang, Y.W. Lin, A. Clemont, E.P. Feener, K.D. Hein, M. Igarashi, T. Yamauchi, M.F. White, and G.L. King Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats J Clin Invest 104 1999 447 457